Vital Farms, Inc. (VITL) shares plummeted 5.11% in the pre-market session on Thursday, despite reporting better-than-expected fourth-quarter earnings. The company's stock took a hit as investors reacted to the ongoing supply constraints caused by the impact of HPAI (Highly Pathogenic Avian Influenza) on poultry flocks across the United States.
The Austin-based company reported a 22.2% increase in net revenue to $166 million for the fourth quarter ended December 29, 2024, driven by volume growth and price/mix benefits. However, the company acknowledged that it had experienced supply constraints at the start of 2025 due to the impact of HPAI on poultry flocks in the U.S.
Despite the challenges, Vital Farms maintained an optimistic outlook for 2025. The company expects its supply chain investments in 2024 and 2025 to bear fruit in the second half of the year, helping drive its net revenue and adjusted EBITDA guidance for 2025. Vital Farms projected net revenue of at least $740 million and adjusted EBITDA of at least $100 million for the full year 2025, representing growth of at least 22% and 15%, respectively, compared to fiscal year 2024.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.